What were Jubilant Pharmova Ltd's latest quarterly results?
Jubilant Pharmova Ltd's latest quarterly results (Mar 2026) show
- PAT Growth YoY: -21.2%
- Revenue Growth YoY: +18.7%
- Operating Margin: 15.0%
Jubilant Pharmova Ltd: Stock Analysis & Fundamentals
Updated this weekJubilant Pharmova Ltd (Pharma - API & CRAMS) — fundamental analysis, earnings data, and key metrics. PE: 35.5. ROE: 6.5%. This stock is not currently in the Nifty 500 momentum outperformers list.
Jubilant Pharmova Ltd Key Facts
What's Happening
💪Debt reduced 20% YoY — balance sheet strengthening
👔Promoter stake down 3.0% this quarter
🌐FII stake decreased 1.4% this quarter
🏛️DII accumulation — stake up 4.9%
Key Numbers
Current Price
₹973
Dividend Yield
0.51%
Market Cap
15.5K Cr
Valuation
N/AOther Top Pharma - API & CRAMS Stocks Beating Nifty 500
Frequently Asked Questions: Jubilant Pharmova Ltd
Based on publicly available financial data. This is educational research, not investment advice.
What is Jubilant Pharmova Ltd's current PE ratio?
Jubilant Pharmova Ltd's current PE ratio is 35.5x.
- Current PE: 35.5x
- Market Cap: 15.5K Cr
- Dividend Yield: 0.51%
What is Jubilant Pharmova Ltd's price-to-book ratio?
Jubilant Pharmova Ltd's price-to-book ratio is 2.2x.
- Price-to-Book (P/B): 2.2x
- Book Value per Share: ₹445
- Current Price: ₹973
Is Jubilant Pharmova Ltd a fundamentally strong company?
Jubilant Pharmova Ltd's fundamental strength based on key financial ratios
- Return on Capital (ROCE): 9.0%
Is Jubilant Pharmova Ltd debt free?
Jubilant Pharmova Ltd has a debt-to-equity ratio of N/A.
- Total Debt: ₹4,000 Cr
What is Jubilant Pharmova Ltd's return on equity (ROE) and ROCE?
Jubilant Pharmova Ltd's return ratios over recent years
- FY2024: ROCE 7.0%
- FY2025: ROCE 10.0%
- FY2026: ROCE 9.0%
Is Jubilant Pharmova Ltd's cash flow positive?
Jubilant Pharmova Ltd's operating cash flow is positive (FY2026).
- Cash from Operations (CFO): ₹1,000 Cr
- Free Cash Flow (FCF): ₹-33 Cr
- CFO/PAT Ratio: 308% (strong cash conversion)
What is Jubilant Pharmova Ltd's dividend yield?
Jubilant Pharmova Ltd's current dividend yield is 0.51%.
- Dividend Yield: 0.51%
- Current Price: ₹973
Who holds Jubilant Pharmova Ltd shares — promoters, FII, DII?
Jubilant Pharmova Ltd's shareholding pattern (Mar 2026)
- Promoters: 47.7%
- FII (Foreign): 15.9%
- DII (Domestic): 11.6%
- Public: 24.3%
Is promoter holding increasing or decreasing in Jubilant Pharmova Ltd?
Jubilant Pharmova Ltd's promoter holding has remained stable recently.
- Current Promoter Holding: 47.7% (Mar 2026)
- Previous Quarter: 47.7% (Dec 2025)
- Change: 0.00% (stable)
Is Jubilant Pharmova Ltd a new momentum entry or an established outperformer?
Jubilant Pharmova Ltd is an established outperformer with 1 weeks of consecutive Nifty 500 outperformance.
Is Jubilant Pharmova Ltd worth studying for long term investment?
Based on quantitative research signals, here is why Jubilant Pharmova Ltd may be worth studying
- Cash flow is positive — CFO ₹1,000 Cr
What is the investment thesis for Jubilant Pharmova Ltd?
Jubilant Pharmova Ltd investment thesis summary:
What is the future outlook for Jubilant Pharmova Ltd?
Jubilant Pharmova Ltd's forward outlook based on current data signals
- Insufficient data for a forward assessment — monitoring for more signals
The above FAQs are generated from publicly available earnings data and conference call transcripts. This is educational research only. Sector Alpha is not SEBI registered and does not provide investment advice.